Theresa Ermer, MD, Dr Med
Hospital Resident, SurgeryCards
Contact Info
About
Copy Link
Titles
Hospital Resident, Surgery
Biography
Theresa is an integrated cardiothoracic surgery resident at Yale, planning to specialize in academic cardiothoracic surgery and lung failure. During medical school in Germany, she spent one year working with the Red Cross in Mexico and received a TRENAL Student Scholarship to complete predoctoral clinical research in Nephrology at University Hospital Erlangen and Yale School of Medicine as part of a 6-year medical research doctorate (Dr. med.), for which she received the Gerda-Weller Prize awarded for one outstanding doctoral thesis per year. She validated a methodology to measure oxalate in the plasma of dialysis patients, led an international clinical study, and helped identify a new risk factor for sudden cardiac death. Before residency, Theresa completed two additional years of postdoctoral research with the Section of Thoracic Surgery at Yale focused on outcomes and disparities in thoracic oncology. Her research efforts have since led to numerous publications in journals (including JAMA and Nature family) and her induction into Sigma Xi. During her first three clinical years, she developed a strong interest in heart and lung failure and cardiothoracic critical care, leading her to most recently join the lab of Dr. Jordan Pober, the Bayer Professor of Translational Medicine and Vice Chair of Immunobiology, for her PhD studies in Investigative Medicine focused on lung transplant rejection. In her free time, she enjoys climbing, weightlifting, and running, as well as exploring snowy Northeast hills, shows in the City, and the myriad vegetarian food options in New Haven.
Education & Training
- Dr Med
- Friedrich-Alexander-Universität Erlangen-Nürnberg, Department of Hypertensiology and Nephrology (2021)
- MD
- Friedrich-Alexander-Universität Erlangen-Nürnberg, Faculty of Medicine (2020)
Research
Copy Link
Overview
Medical Research Interests
Public Health Interests
ORCID
0000-0001-8483-5758
Research at a Glance
Yale Co-Authors
Publications Timeline
Research Interests
Daniel Boffa, MD
Maureen Canavan, PhD, MPH
Andrew Li, MD
Justin D. Blasberg, MD, MPH, FACS
Peter S. Aronson, MD
Felix Knauf, MD
Immunotherapy
Publications
2025
EP.08.46 Neoadjuvant Immunotherapy Improves Recurrence-Free Survival in Resectable Non-Small Cell Lung Cancer - a 10-Year Institutional Experience
Ermer T, Kim S, Goldberg S, Blasberg J, Boffa D, Herbst R, Politi K, Schalper K, Dacic S, Woodard G. EP.08.46 Neoadjuvant Immunotherapy Improves Recurrence-Free Survival in Resectable Non-Small Cell Lung Cancer - a 10-Year Institutional Experience. Journal Of Thoracic Oncology 2025, 20: s769. DOI: 10.1016/j.jtho.2025.09.1483.Peer-Reviewed Original ResearchCardiothoracic Surgery Fellowship Applications
Ahmed A, Colon S, Colon G, Ermer T, Hameed I. Cardiothoracic Surgery Fellowship Applications. The Annals Of Thoracic Surgery 2025 PMID: 40850482, DOI: 10.1016/j.athoracsur.2025.07.049.Peer-Reviewed Original Research
2024
EP.07C.10 Real-World Outcomes of Patients Treated with Neoadjuvant Immunotherapy for Resectable Non-Small Cell Lung Cancer
Ermer T, Kim S, Goldberg S, Zolfaghari E, Blasberg J, Boffa D, Herbst R, Politi K, Schalper K, Dacic S, Woodard G. EP.07C.10 Real-World Outcomes of Patients Treated with Neoadjuvant Immunotherapy for Resectable Non-Small Cell Lung Cancer. Journal Of Thoracic Oncology 2024, 19: s543-s544. DOI: 10.1016/j.jtho.2024.09.1007.Peer-Reviewed Original ResearchCitationsMA04.12 Uncovering Disparities and Trends in Lung Cancer Screening Based on Patient Race and Insurance Status
Zolfaghari E, Tseng R, Sather P, Ermer T, Mase V, Detterbeck F, Tanoue L, Woodard G. MA04.12 Uncovering Disparities and Trends in Lung Cancer Screening Based on Patient Race and Insurance Status. Journal Of Thoracic Oncology 2024, 19: s68. DOI: 10.1016/j.jtho.2024.09.123.Peer-Reviewed Original ResearchInterleukin-16 is increased in dialysis patients but is not a cardiovascular risk factor
Brösecke F, Pfau A, Ermer T, Dein Terra Mota Ribeiro A, Rubenbauer L, Rao V, Burlein S, Genser B, Reichel M, Aronson P, Coca S, Knauf F. Interleukin-16 is increased in dialysis patients but is not a cardiovascular risk factor. Scientific Reports 2024, 14: 11323. PMID: 38760468, PMCID: PMC11101424, DOI: 10.1038/s41598-024-61808-7.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsIL-16 levelsIL-16Dialysis patientsCardiovascular eventsConcentrations of IL-16Kidney failureUremic toxinsCardiovascular diseaseCompared to healthy individualsPlasma oxalate concentrationActivated immune cellsAssociated with cardiovascular diseaseIL-16 concentrationCytokine IL-16Cardiovascular risk factorsNo significant associationPlasma oxalateInflammatory markersImmune cellsCytokine concentrationsInterleukin-16US patientsCohort 1Cardiovascular outcomesHealthy individualsAssociation of patient socioeconomic status with outcomes after palliative treatment for disseminated cancer
Maduka R, Canavan M, Walters S, Ermer T, Zhan P, Kaminski M, Li A, Pichert M, Salazar M, Prsic E, Boffa D. Association of patient socioeconomic status with outcomes after palliative treatment for disseminated cancer. Cancer Medicine 2024, 13: e7028. PMID: 38711364, PMCID: PMC11074703, DOI: 10.1002/cam4.7028.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsOptimal quality of careQuality of carePatient socioeconomic statusAssociated with improved qualityAssociated with improved quality of lifeEnd-of-lifeUS cancer populationPalliative treatmentQuality of lifeCox proportional hazards modelsMultivariate logistic regressionInformed decision makingProportional hazards modelFacility characteristicsNon-HispanicAssociated with lower ratesInsurance payer statusImproving informed decision makingCancer populationSocioeconomic statusHispanic ethnicityTreatment usePayer statusBlack raceLogistic regression
2023
Respect the Middle Lobe: Perioperative Risk of Bilobectomy Compared With Lobectomy and Pneumonectomy
Li A, Canavan M, Ermer T, Maduka R, Zhan P, Pichert M, Boffa D, Blasberg J. Respect the Middle Lobe: Perioperative Risk of Bilobectomy Compared With Lobectomy and Pneumonectomy. The Annals Of Thoracic Surgery 2023, 117: 163-171. PMID: 37774762, DOI: 10.1016/j.athoracsur.2023.09.023.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsLower bilobectomyLeft pneumonectomyLung cancerMiddle lobeRight-sided lung cancerCox proportional hazards modelThirty-day morbidityTotal lung functionPreoperative risk stratificationThoracic Surgeons databaseProportional hazards modelPneumonectomy patientsUpper bilobectomyBronchial involvementPerioperative mortalityPerioperative riskPerioperative variablesPatient demographicsPulmonary resectionRight pneumonectomySecondary outcomesLung functionMiddle lobectomyPrimary outcomePropensity matchingAssessment of a collaborative treatment model for trimodal management of esophageal cancer
Udelsman B, Ermer T, Ely S, Canavan M, Zhan P, Boffa D, Blasberg J. Assessment of a collaborative treatment model for trimodal management of esophageal cancer. Journal Of Thoracic Disease 2023, 15: 4668-4680. PMID: 37868899, PMCID: PMC10586936, DOI: 10.21037/jtd-23-346.Peer-Reviewed Original ResearchCitationsConceptsPathologic complete responseNational Cancer DatabaseGy of radiationEsophageal cancerCollaborative treatmentCollaborative treatment modelMultiagent chemotherapySingle institutionRate of pCRPatient travel burdenR0 resection rateTreatment modelTrimodality therapyTrimodality treatmentNeoadjuvant chemoradiotherapyNeoadjuvant therapyR0 resectionResection rateComplete responseMultivariable analysisTumor characteristicsCancer DatabaseMedian travel distancePatientsCollaborative CohortASO Visual Abstract: Association Between Metastatic Pattern and Prognosis in Stage IV Gastric Cancer—Potential for Stage Classification Reform
Zhan P, Canavan M, Ermer T, Pichert M, Li A, Maduka R, Udelsman B, Nemeth A, Boffa D. ASO Visual Abstract: Association Between Metastatic Pattern and Prognosis in Stage IV Gastric Cancer—Potential for Stage Classification Reform. Annals Of Surgical Oncology 2023, 30: 4192-4192. DOI: 10.1245/s10434-023-13397-4.Peer-Reviewed Original ResearchAssociation Between Metastatic Pattern and Prognosis in Stage IV Gastric Cancer: Potential for Stage Classification Reform
Zhan P, Canavan M, Ermer T, Pichert M, Li A, Maduka R, Udelsman B, Nemeth A, Boffa D. Association Between Metastatic Pattern and Prognosis in Stage IV Gastric Cancer: Potential for Stage Classification Reform. Annals Of Surgical Oncology 2023, 30: 4180-4191. PMID: 36869917, DOI: 10.1245/s10434-023-13287-9.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsStage IV gastric cancerNonregional lymph nodesMultivariable Cox modelLymph nodesGastric cancerMetastatic patternCox modelStage IV gastric cancer patientsBetter median survivalNational Cancer DatabaseRetrospective cohort studyStage IV patientsKaplan-Meier curvesGastric cancer patientsPropensity score-matched sampleSingle organYears of ageDistant diseaseCohort studyIV patientsMedian survivalMetastatic diseaseMost patientsBetter prognosisSystemic organs
Get In Touch
Copy Link